Research programme: NMDA receptor antagonists - Gedeon Richter

Drug Profile

Research programme: NMDA receptor antagonists - Gedeon Richter

Alternative Names: N-methyl-D-aspartate receptor agonists - Gedeon Richter

Latest Information Update: 26 Jul 2010

Price : $50

At a glance

  • Originator Gedeon Richter
  • Class
  • Mechanism of Action NMDA receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Preclinical Neuropathic pain; Pain

Most Recent Events

  • 26 Jul 2010 Preclinical development is ongoing in Hungary
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top